BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30294786)

  • 1. International validation of harmonized definitions for complications of blood donations.
    Land KJ; Townsend M; Goldman M; Whitaker BI; Perez GE; Wiersum-Osselton JC
    Transfusion; 2018 Nov; 58(11):2589-2595. PubMed ID: 30294786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of standard definitions for surveillance of complications related to blood donation.
    Goldman M; Land K; Robillard P; Wiersum-Osselton J
    Vox Sang; 2016 Feb; 110(2):185-8. PubMed ID: 26361365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of donor adverse reaction severity grading tool: enhancing objective grade assignment to donor adverse events.
    Townsend M; Kamel H; Van Buren N; Wiersum-Osselton J; Rosa-Bray M; Gottschall J; Rajbhandary S
    Transfusion; 2020 Jun; 60(6):1231-1242. PubMed ID: 32452048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
    Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
    Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AABB validation study of the CDC's National Healthcare Safety Network Hemovigilance Module adverse events definitions protocol.
    AuBuchon JP; Fung M; Whitaker B; Malasky J
    Transfusion; 2014 Aug; 54(8):2077-83. PubMed ID: 24673261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
    Cho JH; Rajbhandary S; van Buren NL; Fung MK; Al-Ghafry M; Fridey JL; Dy BA; Ziman A; Schreiber GB; Gammon RR; Reik R; Stubbs JR; van Buskirk CM; Kamel H; Townsend MJ; Zeller MP; Gottschall JL
    Transfusion; 2021 Sep; 61(9):2668-2676. PubMed ID: 34227689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study.
    Wiersum-Osselton JC; Whitaker B; Grey S; Land K; Perez G; Rajbhandary S; Andrzejewski C; Bolton-Maggs P; Lucero H; Renaudier P; Robillard P; Santos M; Schipperus M
    Lancet Haematol; 2019 Jul; 6(7):e350-e358. PubMed ID: 31080132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International haemovigilance: what have we learned and what do we need to do next?
    Wood EM; Ang AL; Bisht A; Bolton-Maggs PH; Bokhorst AG; Flesland O; Land K; Wiersum-Osselton JC; Schipperus MR; Tiberghien P; Whitaker BI
    Transfus Med; 2019 Aug; 29(4):221-230. PubMed ID: 30729612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration.
    Mikkelsen C; Paarup HM; Bruun MT; Pedersen LØ; Hasslund S; Larsen R; Aagaard B; Sørensen BS
    Vox Sang; 2022 Mar; 117(3):321-327. PubMed ID: 34523137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-associated hazards: A revisit of their presentation.
    Garraud O; Sut C; Haddad A; Tariket S; Aloui C; Laradi S; Hamzeh-Cognasse H; Bourlet T; Zeni F; Aubron C; Ozier Y; Laperche S; Peyrard T; Buffet P; Guyotat D; Tavernier E; Cognasse F; Pozzetto B; Andreu G
    Transfus Clin Biol; 2018 May; 25(2):118-135. PubMed ID: 29625790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syphilis screening practices in blood transfusion facilities in Ghana.
    Sarkodie F; Hassall O; Owusu-Dabo E; Owusu-Ofori S; Bates I; Bygbjerg IC; Ansah JK; Ullum H
    Int J Infect Dis; 2016 Feb; 43():90-94. PubMed ID: 26751240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of mandating a dedicated hemovigilance nurse and objectification of 'imputability' levels. Experience from a hospital-based blood centre in India.
    Dhiman Y; Raturi M; Kala M; Kusum A
    Transfus Clin Biol; 2023 Feb; 30(1):96-102. PubMed ID: 36162622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [International databases: usefulness and limitations in hemovigilance].
    Wiersum-Osselton JC
    Transfus Clin Biol; 2010 Dec; 17(5-6):306-9. PubMed ID: 21055991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty years of hemovigilance - Achievements and future perspectives.
    Vuk T; Politis C; Laspina S; Lozano M; Haddad A; de Angelis V; Garraud O;
    Transfus Clin Biol; 2023 Feb; 30(1):166-172. PubMed ID: 36216308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized reporting of pulmonary transfusion complications: Development of a model reporting form and flowchart.
    van Wonderen SF; Peters AL; Grey S; Rajbhandary S; de Jonge LL; Andrzejewski C; Narayan S; Wiersum-Osselton JC; Vlaar APJ
    Transfusion; 2023 Jun; 63(6):1161-1171. PubMed ID: 37060282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.
    Eder AF; Dy BA; Kennedy JM; Notari Iv EP; Strupp A; Wissel ME; Reddy R; Gibble J; Haimowitz MD; Newman BH; Chambers LA; Hillyer CD; Benjamin RJ
    Transfusion; 2008 Sep; 48(9):1809-19. PubMed ID: 18631167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.
    Edens C; Haass KA; Cumming M; Osinski A; O'Hearn L; Passanisi K; Eaton L; Visintainer P; Savinkina A; Kuehnert MJ; Basavaraju SV; Andrzejewski C
    Transfusion; 2019 Feb; 59(2):524-533. PubMed ID: 30427540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
    Py JY; Durieux S; Barnoux M; Sapey T
    Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.